accounta biosimilars business, currently a hot area for big pharma. Wockhardt has already sold its nutritionals division to Abbott Laboratories for $130 million, 10 hospitals to Fortis Healthcare for $186 million, an animal health division to France’s...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to India’s Rich Pickings For Pharma M
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account